← Back to headlines

Sunvozertinib Monotherapy Bests Platinum-Doublet Chemotherapy in EGFR Exon 20+ NSCLC

This story is reported by OncLive. Read what other outlets are saying below, then open the original report for full details.

Sunvozertinib Monotherapy Bests Platinum-Doublet Chemotherapy in EGFR Exon 20+ NSCLC · NabkaNews